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Abstract
Group A streptococcal (S. pyogenes; GAS) infection is endemic in the Northern
Territory of Australia, and the rates of invasive GAS disease and post-infection sequelae
are among the highest reported in the world. Plasminogen is a potent human protease
sequestered to the GAS cell-surface by plasminogen and fibrinogen receptors and
activated by GAS streptokinase and host plasminogen activators. The critical role of
plasminogen in GAS invasion was recently demonstrated in a human plasminogen
transgenic mouse model of infection.

The aim of this study was to determine whether plasminogen is deployed as a virulence
factor in invasive GAS disease, with particular reference to the Northern Territory of
Australia. This question was first approached from an epidemiological perspective,
comparing Northern Territory GAS isolates from invasive infections with those from
uncomplicated infections for their interaction with the plasminogen system.
Plasminogen binding; plasminogen receptor expression and genetic variation;
fibrinogen

binding;

streptokinase

expression,

activity and genetic variation;

streptococcal pyrogenic exotoxin B (SpeB) expression and activity; and acquisition of
cell-surface plasmin in human plasma were characterised for 29 GAS isolates of known
clinical origin from the Northern Territory. The second approach to determining the role
of plasminogen in invasive disease in the Northern Territory was to investigate GAS
infection using a human plasminogen transgenic mouse model. A subset of Northern
Territory GAS isolates selected for different in vitro plasminogen activation
characteristics was tested for virulence in this model.

xviii

This study revealed that Northern Territory GAS isolates from invasive disease cases
acquire more plasminogen than isolates from uncomplicated infections, however they
do not produce more streptokinase nor acquire more cell-surface plasmin after
incubation in human plasma in vitro. Presence of the gene for the plasminogen-binding
group A streptococcal M-like protein (PAM) conferred upon GAS isolates a strikingly
different profile of interaction with plasminogen, characterised by higher plasminogen
binding and plasmin acquisition in plasma. Differences in the catalytic specificity of
streptokinase secreted by pam-positive and pam-negative isolates were identified and
their allelic determinants investigated. A new model of GAS cell-surface plasminogen
activation is proposed for pam-positive isolates. To characterise the role of
streptokinase and the cysteine protease SpeB in acquisition of cell-surface plasmin
activity in human plasma, such acquisition was compared in GAS deletion mutants for
genes encoding these proteins and the corresponding wildtype strains. The dramatic
reduction of GAS cell-surface plasmin activity by SpeB may significantly disable GAS
invasive potential. Infection studies in the human plasminogen transgenic mouse model
revealed the critical role of plasminogen in virulence of some Northern Territory
isolates, however in vitro plasminogen activation characteristics do not predict clinical
phenotype nor virulence in the transgenic mouse model. The results suggest an
important and complex interaction between plasminogen and other host and/or bacterial
factors in establishing invasive GAS infection in the Northern Territory of Australia.
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